In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

An increasing body of evidence supports the validity of self-sampling as an alternative to
clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling …

High‐risk human papillomavirus (hr‐HPV) detection will become an important tool in the
screening for cervical cancer. Self‐sampling is an inexpensive and well‐accepted method …

In 2018, there were an estimated 570,000 new cases of cervical cancer globally, with most
of them occurring in women who either had no access to cervical screening, or had not …

In 2016, the Netherlands will switch, as first European country, from cytology-based to HPV-
based cervical cancer screening, with cytology triage for those with a positive HPV test. The …

Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Background In the last decade, human papillomavirus (HPV) testing has been evaluated
extensively for cervical screening, with studies finding increased sensitivity compared to …

Objectives: Women in safety-net institutions are less likely to receive cervical cancer
screening. Human papilloma virus (HPV) self-sampling is an alternative method of cervical …

Background Human papillomavirus (HPV) testing is recommended in primary cervical
screening to improve cancer prevention. An advantage of HPV testing is that it can be …